Clinical trial
Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With…
NCT00125203 · The University of Texas Health Science Center at San Antonio, Other · Completed
Key facts
| NCT number | NCT00125203 |
|---|---|
| Title | Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Safety and Efficacy of Botulinum Toxin Type B (Myobloc) in Sialorrhea in Amyotrophic Lateral Sclerosis |
| Lead sponsor | The University of Texas Health Science Center at San Antonio, Other |
| Collaborators | ALS Association University of Kansas Carolinas MDA Neuromuscular/ALS Center-Carolinas Medical System |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis, Sialorrhea |
| Intervention type | Drug, Procedure |
| Interventions | Botulinum toxin type B (Myobloc), Injection of salivary glands |
| Enrollment | 20 |
| Start date | Jul 1, 2003 |
| Completion | Aug 1, 2007 |
| First posted | Jul 29, 2005 |
| Last update posted | Mar 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: